Purdue Pharma LP has named Margaret Feltz vice president and chief ethics/compliance officer, reporting to President and CEO Mark Timney.
“At a time of transformation for Purdue, it is critical we maintain our commitment to the highest ethical standards and continued compliance with all laws, regulations and company policies,” Timney said in a statement. “Maggie is an excellent choice to help us achieve these goals.”
Feltz will oversee the company’s overall ethics and compliance strategy and leadership, technical direction and guidance. She will also take a seat on the company’s executive committee.
“Both as an individual leader and industry expert, Bert has had a profound impact on the field of pharmaceutical compliance,” Timney said. “Under his leadership, Purdue built industry-leading compliance strategies, programs and a corporate culture that has increased compliance awareness and reduced regulatory risk.”
Feltz comes to Purdue after stints at McDermott, Will & Emery and Boehringer Ingelheim Pharmaceuticals Inc. She previously worked for Purdue Pharma, starting in 2004 in the company’s compliance program.
Feltz earned her Juris Doctor degree at Case Western University Law School.